Replies to post #70341 on Biotech Values

[DewDiligence]

NEOP – Thanks for your reply. Any company that pays for analyst reports is one I would exclude from consideration on the long side.

I haven’t followed NEOP in a long time, but I thought the company was guilty of some serious hyping about 4.5 years ago. Here are a few old posts for anyone who’s curious:

#msg-2728519
#msg-2694917
#msg-2949418
#msg-3070547
#msg-3160241